AKR1B10 抗体
(Aldo-Keto Reductase Family 1, Member B10 (Aldose Reductase) (AKR1B10))
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member can efficiently reduce aliphatic and aromatic aldehydes, and it is less active on hexoses. It is highly expressed in adrenal gland, small intestine, and colon, and may play an important role in liver carcinogenesis. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| AKR1B10 抗体 (AA 76-143) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1B10 抗体 | 人 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 (AA 76-144) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1B10 抗体 (AA 76-143) | 人 | 小鼠 Polyclonal |
|
|
|
| AKR1B10 抗体 (AA 1-316) | 人 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 (AA 76-143) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1B10 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 (C-Term) | 人 | 山羊 Polyclonal |
|
|
|
| AKR1B10 抗体 (AA 1-316) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 (AA 51-100) | 人, 小鼠, 马, 斑马鱼 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 (AA 1-316) | 人 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 (AA 101-130) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 (AA 101-130) (PE) | 人 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 (AA 101-130) (APC) | 人 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 (AA 101-130) | 人 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 (AA 1-316) | 人 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 (AA 285-316) | 人 | 兔 Polyclonal |
|
|
|
| AKR1B10 抗体 (N-Term) | 人, 小鼠, 大鼠, 马, 斑马鱼, Cow, 犬, 豚鼠, 兔, Saccharomyces cerevisiae | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ISt (Immunostaining: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
8 references - 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1A6
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 76-143
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 有验证图片)
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1A6
- 标记
- unconjugated
- 抗体亚型
- IgG2a kappa
- 抗原表位
- AA 76-144
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 76-143
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-316
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2B3
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 76-143
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 质量等级
- Verified
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-316
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-316
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 101-130
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 101-130
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 101-130
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 101-130
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-316
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 285-316
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, 马, 斑马鱼, Cow, 犬, 豚鼠, 兔, Saccharomyces cerevisiae
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Latest Publications for our AKR1B10 抗体
: "Quantification of the host response proteome after herpes simplex virus type 1 infection." in: Journal of proteome research, Vol. 14, Issue 5, pp. 2121-42, (2015) (PubMed).
: "Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions." in: Human pathology, Vol. 45, Issue 4, pp. 834-43, (2014) (PubMed).
: "SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma." in: Journal of hepatology, Vol. 59, Issue 3, pp. 510-7, (2013) (PubMed).
: "Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 25, Issue 5, pp. 758-66, (2012) (PubMed).
: "A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals." in: Scientific reports, Vol. 2, pp. 280, (2012) (PubMed).
: "An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma." in: The Journal of pathology, Vol. 228, Issue 3, pp. 274-85, (2012) (PubMed).
: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
: "AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases." in: Liver international : official journal of the International Association for the Study of the Liver, Vol. 31, Issue 6, pp. 810-6, (2011) (PubMed).
: "Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity." in: Cancer research, Vol. 71, Issue 12, pp. 4161-71, (2011) (PubMed).
: "Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin." in: The Journal of pharmacology and experimental therapeutics, Vol. 335, Issue 3, pp. 533-45, (2010) (PubMed).
: "Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions." in: Human pathology, Vol. 45, Issue 4, pp. 834-43, (2014) (PubMed).
: "SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma." in: Journal of hepatology, Vol. 59, Issue 3, pp. 510-7, (2013) (PubMed).
: "Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma." in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 25, Issue 5, pp. 758-66, (2012) (PubMed).
: "A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals." in: Scientific reports, Vol. 2, pp. 280, (2012) (PubMed).
: "An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma." in: The Journal of pathology, Vol. 228, Issue 3, pp. 274-85, (2012) (PubMed).
: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
: "AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases." in: Liver international : official journal of the International Association for the Study of the Liver, Vol. 31, Issue 6, pp. 810-6, (2011) (PubMed).
: "Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity." in: Cancer research, Vol. 71, Issue 12, pp. 4161-71, (2011) (PubMed).
: "Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin." in: The Journal of pharmacology and experimental therapeutics, Vol. 335, Issue 3, pp. 533-45, (2010) (PubMed).
Aliases for AKR1B10 抗体
aldo-keto reductase family 1 member B10 (AKR1B10) 抗体aldo-keto reductase family 1, member B10 (aldose reductase) (Akr1b10) 抗体
aldo-keto reductase family 1 member B10-like 2 (AKR1B10L2) 抗体
aldo-keto reductase family 1 member B10 (Akr1b10) 抗体
aldo-keto reductase family 1 member B10 (LOC100585902) 抗体
aldo-keto reductase family 1 member B10 (LOC100723118) 抗体
aldo-keto reductase family 1 member B10 (LOC101107697) 抗体
2310005E10Rik 抗体
AKR 抗体
AKR1B10 抗体
Akr1b10 抗体
AKR1B11 抗体
AKR1B12 抗体
Akr1b16 抗体
ALDRLn 抗体
ARL-1 抗体
ARL1 抗体
HIS 抗体
HSI 抗体
您还需要查找其他产品吗？
- AKR1B1 抗体
- AKR1A1 抗体
- AKNA Domain Containing 1 抗体
- AKNA 抗体
- AKIRIN2 抗体
- AKIP1 抗体
- AKAP9 抗体
- AKAP8L 抗体
- AKAP8 抗体
- AKAP7 抗体
- AKAP6 抗体
- AKAP5 抗体
- AKAP4 抗体
- AKAP3 抗体
- AKAP2 抗体
- AKAP14 抗体
- AKAP13 抗体
- AKAP12 抗体
- AKAP11 抗体
- AKAP10 抗体
- AKR1C1 抗体
- AKR1C2 抗体
- AKR1C3 抗体
- AKR1C4 抗体
- AKR1D1 抗体
- AKR1E2 抗体
- AKR7A2 抗体
- AKR7A3 抗体
- AKT Interacting Protein 抗体
- AKT2 抗体
- AKT3 抗体
- ALAD 抗体
- Alanine Glyoxylate Aminotransferase 抗体
- Alanyl (Membrane) Aminopeptidase 抗体
- Alanyl-tRNA Synthetase 抗体
- ALAS1 抗体
- ALAS2 抗体
- Albumin 抗体
- Alcohol Dehydrogenase 抗体
- Alcohol Dehydrogenase 7 (Class IV), mu Or sigma Polypeptide 抗体
You are here:
